BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
3/29/2016 3:29:00 PM | Browse: 1355 | Download: 2749
 |
Received |
|
2015-08-29 16:59 |
 |
Peer-Review Started |
|
2015-09-01 09:52 |
 |
First Decision by Editorial Office Director |
|
|
 |
Return for Revision |
|
2015-10-08 17:29 |
 |
Revised |
|
2015-11-02 21:28 |
 |
Publication Fee Transferred |
|
|
 |
Second Decision by Editor |
|
2016-01-06 11:38 |
 |
Second Decision by Editor-in-Chief |
|
|
 |
Final Decision by Editorial Office Director |
|
2016-01-18 10:21 |
 |
Articles in Press |
|
2016-01-18 10:21 |
 |
Edit the Manuscript by Language Editor |
|
2016-03-02 09:19 |
 |
Typeset the Manuscript |
|
2016-03-15 10:45 |
 |
Publish the Manuscript Online |
|
2016-03-29 15:29 |
| ISSN |
1007-9327 (print) and 2219-2840 (online) |
| Open Access |
This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2016. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Medicine, Research & Experimental |
| Manuscript Type |
Basic Study |
| Article Title |
Evaluation of therapeutic effectiveness of 131I-antiEGFR-BSA-PCL in a mouse model of colorectal cancer
|
| Manuscript Source |
Unsolicited Manuscript |
| All Author List |
Wei Li, Yan-Hui Ji, Cheng-Xia Li, Zhong-Yun Liu, Ning Li, Lei Fang, Jin Chang and Jian Tan |
| Funding Agency and Grant Number |
| Funding Agency |
Grant Number |
| National Natural Science Foundation of China |
81301244 (to Li W) |
| National Key Clinical Specialty Project |
|
|
| Corresponding Author |
Jian Tan, MD, Professor of Medicine, Chief, Department of Nuclear Medicine, Tianjin Medical University General Hospital, Anshan Road 154, Heping District, Tianjin 300052, China. tanpost@163.com |
| Key Words |
Radioiodine therapy; Colorectal cancer; Liposome; Epidermal growth factor receptor; Mouse |
| Core Tip |
This paper describes liposomes that were assessed for EGFR-targeted binding and cellular uptake in EGFR-overexpressing LS180 colorectal cancer cells and a mouse model of colorectal cancer. Anti-EGFR and non-targeted liposomes were labeled with 131I using the chloramine-T method. The time-dependent cellular uptake of 131I-antiEGFR-BSA-PCL and 131I-BSA-PCL demonstrated the slow-release effects of nanoparticles. The results of confocal microscopic analysis revealed the significant uptake of antiEGFR-BSA-PCL in LS180 cells. This study also investigated the biological effects of internal irradiation and the therapeutic efficacy of 131I-antiEGFR-BSA-PCL on colorectal cancer in a BALB/c mouse model. To address this issue, tumor size, body weight, histopathology, and SPECT imaging were monitored for 33 d post-therapy. The 131I-antiEGFR-BSA-PCL was demonstrated to be superior in regard to cellular binding and uptake compared with control BSA-PCL in the mouse model. |
| Publish Date |
2016-03-29 15:29 |
| Citation |
Li W, Ji YH, Li CX, Liu ZY, Li N, Fang L, Chang J, Tan J. Evaluation of therapeutic effectiveness of 131I-antiEGFR-BSA-PCL in a mouse model of colorectal cancer. World J Gastroenterol 2016; 22(14): 3758-3768 |
| URL |
http://www.wjgnet.com/1007-9327/full/v22/i14/3758.htm |
| DOI |
http://dx.doi.org/10.3748/wjg.v22.i14.3758 |
All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.